Drug Type AAV based gene therapy |
Synonyms Adeno-associated virus vector serotype SAN011 encoding a microRNA against DMPK mRNA |
Target |
Action inhibitors |
Mechanism DMPK inhibitors(DM1 protein kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Myotonic Dystrophy | Preclinical | Switzerland | 11 Oct 2024 |





